相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors
Laura Prakash et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Relevance of dihydropyrimidine-dehydrogenase and thymidylate-synthase in patients with pancreatic neuroendocrine neoplasms treated with 5-FU-based chemotherapy
S. Krug et al.
PANCREATOLOGY (2017)
Impact of Therapy Sequence with Alkylating Agents and MGMT Status in Patients with Advanced Neuroendocrine Tumors
Sebastian Krug et al.
ANTICANCER RESEARCH (2017)
Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity
Pantelis Clewemar Antonodimitrakis et al.
NEUROENDOCRINOLOGY (2016)
Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?
Angela Lamarca et al.
CANCER TREATMENT REVIEWS (2016)
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
M. Pavel et al.
NEUROENDOCRINOLOGY (2016)
Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours
Lisa-Marie Dilz et al.
EUROPEAN JOURNAL OF CANCER (2015)
Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan
Taku Aoki et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
Tetsuhide Ito et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms - Predictive and Prognostic Markers for Treatment Stratification
Sebastian Krug et al.
PLOS ONE (2015)
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) - A phase II non-randomised trial
Michel Ducreux et al.
EUROPEAN JOURNAL OF CANCER (2014)
A single institution experience of streptozocin/fluorouracil combination chemotherapy: a case series
J. Naidoo et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2012)
First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas
Jonathan R. Strosberg et al.
CANCER (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
N. C. Turner et al.
BRITISH JOURNAL OF CANCER (2010)
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan
Tetsuhide Ito et al.
JOURNAL OF GASTROENTEROLOGY (2010)
O-6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
Matthew H. Kulke et al.
CLINICAL CANCER RESEARCH (2009)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma: a judicious option?
T Delaunoit et al.
EUROPEAN JOURNAL OF CANCER (2004)
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors
AD McCollum et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
分享论文
